Skip to content

DBS recallZ-0217-2024 · Medtronic Neuromodulation · initiated May 27, 2022

Completed

Is my device affected?

  1. Compare the model, catalog and lot or serial numbers on your device or its packaging with the code information below. A recall usually covers only specific models or lots.
  2. If yours is listed, follow the instructions from Medtronic Neuromodulation or your healthcare provider. The company's action is summarized under what the company is doing.
  3. Do not stop using a prescribed or implanted device on your own — talk to your healthcare provider first.

Where to find your model and lot numbers · What recall classes and statuses mean

Why it was recalled

There are a small number of units of the DBS Lead with StimLoc kit (3387S-40) due to a discrepancy in the Use By Date (UBD) printed on the outer packaged kit label versus the UBD printed on the individual product label.

FDA root cause category: Labeling Change Control

What the company is doing

Medtronic issued a Medical Device Removal notice to its consignees on 05/27/2023 by US mail. The notice explained the issue, potential risk, and requested the return of the affected product.

Recall details

Recall number
Z-0217-2024
Status
Completed
Initiated by the company
May 27, 2022
Posted by the FDA
Nov 3, 2023
Recalling firm
Medtronic Neuromodulation
Quantity
14 units
Product code
MHY
FDA submissions
P960009
Distribution
US: MO, FL, TX, WA

Product description

LEAD 3387S-40 STIMLOC DBS, Model Number 3387S-40. Electrical implantable device.

Code information (models, lots, serial numbers)

UDI/DI 00763000274320, Serial Number VA2JV2V

Devices named in this recall

1 device in the FDA device registry whose identifier appears in the recall's code information.

Product lines

Other devices under the same FDA submission

89 devices cleared under P960009 are not named by identifier in this recall. One submission often covers many models, so they may or may not be affected.

Sources and updates

How recalls are matched to devices · Editorial policy · Report an error on this page